Beruflich Dokumente
Kultur Dokumente
Dynamic Marketing Budget Allocation across Countries, Products, and Marketing Activities
Marc Fischer (University of Passau) Snke Albers (Christian-Albrechts-University at Kiel) Nils Wagner (University of Passau) Monika Frie (Bayer AG)
EUR 29 bn (US$ 40 bn) sales 106,000 employees worldwide EBITDA EUR 5.5 bn (US$ 7.8 bn) Very comfortable 20% EBITDA margin
Gut feeling guides management decisions Very strong influence of negotiation skills Local managers learn how to manipulate allocation process
Politics and tensions shape the decision process instead of fact-based discussions
The profit improvement potential from better allocation of a total marketing budget is much higher than from optimizing the total budget!
Implementation
Impact
AGENDA
The Allocation Problem Company and Market Background Problem Solution The Allocation
Heuristic
Leading brands Adalat Avelox Ciprobay EUR 626 m (US$ 870 m) EUR 445 m (US$ 618 m) EUR 338 m (US$ 470 m) EUR 341 m (US$ 474 m) EUR 304 m (US$ 423 m)
Levitra Glucobay
Physician oriented
Marketing activities Direct-to-consumer advertising (only US) Patient oriented Below the lineactivities (e.g., PR)
10
AGENDA
The Allocation Problem Company and Market Background Problem Solution The Allocation
Heuristic
11
(tT)
Unit saleskit
(kK)
(iIk)
kint
Max!
Discounted net value of product portfolio where Unit sales = f(life cycle, marketing expense, etc.)
Restrictions
12
Optimal solution
Optimal allocation weightkint
Optimal budgetkint =
Total budget
Profit con- Optimal unit Optimal mktg.+ Optimal growth tributionkit saleskit elasticitykint elasticitykit 1 + Discount rate Marketing carryoverkin
13
1
(Discounted) long-term marketing effectiveness
2
Size of profit contribution
3
Growth potential
(T = Planning horizon)
14
Both scenarios
Degree of suboptimality (profits)
Monopoly
Duopoly
5% 4% 3% 2% 1% 0% 1 3 5 7 9 11
Planning cycle
15
10 years (1996-2006) of quarterly marketing and sales data Countries: France, Germany, Italy, Spain, U.K.
16
Type
Marketing mix
Other variables
17
Model fit
Holdout prediction
Marketing effects
18
AGENDA
The Allocation Problem Company and Market Background Problem Solution The Allocation
Heuristic
19
1. 2.
20
Total
100%
100%
+ 685.73
+ 54.9%
+ 10% in EBITDA (= US$ 380 m) for Bayers prescription drug business in 2008 (Bayer Annual Report 2008)
Fischer, Albers, Wagner, and Frie (Dynamic Marketing Budget Allocation)
21
3.2 m
22
63.7 m
2.4 m
.3 m SP detailing
GP detailing
23
24
1
Easy to extend to other industries
2
No specific requirements for market response model
3
No specific requirements for type of data
25
26